Xiaoling Luo

905 total citations
31 papers, 528 citations indexed

About

Xiaoling Luo is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Xiaoling Luo has authored 31 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cancer Research, 14 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Xiaoling Luo's work include Cancer-related molecular mechanisms research (10 papers), Circular RNAs in diseases (7 papers) and MicroRNA in disease regulation (6 papers). Xiaoling Luo is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), Circular RNAs in diseases (7 papers) and MicroRNA in disease regulation (6 papers). Xiaoling Luo collaborates with scholars based in China, United States and Egypt. Xiaoling Luo's co-authors include Xiaoyun Shen, Xinping Huang, Chao‐Yuan Huang, Yan Feng, Yali Gao, Rong Liang, Yuan Xie, Litu Zhang, Jin Hou and Xuehui Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Frontiers in Immunology.

In The Last Decade

Xiaoling Luo

29 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoling Luo China 15 347 257 94 63 55 31 528
Lin Zou China 15 531 1.5× 310 1.2× 105 1.1× 59 0.9× 46 0.8× 27 760
Xingsi Liang China 11 404 1.2× 213 0.8× 86 0.9× 39 0.6× 35 0.6× 12 546
Jiapeng Xu China 11 279 0.8× 135 0.5× 64 0.7× 48 0.8× 54 1.0× 24 438
Aimin Zang China 11 248 0.7× 189 0.7× 116 1.2× 51 0.8× 25 0.5× 47 428
Bing Wei China 15 408 1.2× 283 1.1× 64 0.7× 55 0.9× 41 0.7× 33 622
Yanping Li China 11 254 0.7× 218 0.8× 110 1.2× 25 0.4× 59 1.1× 34 483
Yanyi Xiao China 14 280 0.8× 121 0.5× 121 1.3× 41 0.7× 36 0.7× 22 457
Nageswara Rao Dunna India 14 369 1.1× 239 0.9× 81 0.9× 45 0.7× 22 0.4× 34 575
Yong Luo China 13 250 0.7× 157 0.6× 82 0.9× 42 0.7× 20 0.4× 31 398

Countries citing papers authored by Xiaoling Luo

Since Specialization
Citations

This map shows the geographic impact of Xiaoling Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Luo more than expected).

Fields of papers citing papers by Xiaoling Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoling Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Luo. The network helps show where Xiaoling Luo may publish in the future.

Co-authorship network of co-authors of Xiaoling Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoling Luo. A scholar is included among the top collaborators of Xiaoling Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoling Luo. Xiaoling Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Xiaoling, Ahmed H. El‐Sappah, Mahmoud M. Azzam, et al.. (2025). Antibiotic resistance in Helicobacter pylori: a genetic and physiological perspective. Gut Pathogens. 17(1). 35–35. 3 indexed citations
2.
Luo, Xiaoling, et al.. (2025). Immunoglobulin Y antibodies against colonization-related genes block the growth and infection of Helicobacter pylori. Frontiers in Immunology. 16. 1582250–1582250. 1 indexed citations
3.
Zhu, Yueyong, Zhi Yang, Xiaoling Luo, & Peng Xu. (2021). Long noncoding RNA TTN-AS1 promotes the proliferation and migration of prostate cancer by inhibiting miR-1271 level. SHILAP Revista de lepidopterología. 4 indexed citations
4.
5.
Ye, Jiaxiang, Haixia Li, Jiazhang Wei, et al.. (2020). Risk Scoring System based on lncRNA Expression for Predicting Survival in Hepatocellular Carcinoma with Cirrhosis. Asian Pacific Journal of Cancer Prevention. 21(6). 1787–1795. 18 indexed citations
6.
Gao, Yali, Xiaoling Luo, & Jun Zhang. (2020). Sp1-mediated up-regulation of lnc00152 promotes invasion and metastasis of retinoblastoma cells via the miR-30d/SOX9/ZEB2 pathway. Cellular Oncology. 44(1). 61–76. 19 indexed citations
7.
Ye, Jiaxiang, Jinyan Zhang, Yufeng Lv, et al.. (2019). Integrated analysis of a competing endogenous RNA network reveals key long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma. Journal of Cellular Biochemistry. 120(8). 13810–13825. 35 indexed citations
8.
Liang, Rong, Yan Lin, Jiazhou Ye, et al.. (2017). High expression of RBM8A predicts poor patient prognosis and promotes tumor progression in hepatocellular carcinoma. Oncology Reports. 37(4). 2167–2176. 25 indexed citations
9.
Huang, Chao‐Yuan, et al.. (2017). MicroRNA-144-3p suppresses tumor growth and angiogenesis by targeting SGK3 in hepatocellular carcinoma. Oncology Reports. 38(4). 2173–2181. 38 indexed citations
10.
Liang, Rong, Yan Lin, Chunling Yuan, et al.. (2017). The clinical significance and biological function of large tumour suppressor 2 in hepatocellular carcinoma. Cell Proliferation. 50(3). 3 indexed citations
11.
Yuan, Chunling, Fan He, Jiazhou Ye, et al.. (2017). APE1 overexpression is associated with poor survival in patients with solid tumors: a meta-analysis. Oncotarget. 8(35). 59720–59728. 30 indexed citations
12.
Liu, Siyu, Peng Xu, Xiaoling Luo, Jin‐Feng Hu, & Xinhua Liu. (2016). (7R,8S)-Dehydrodiconiferyl Alcohol Suppresses Lipopolysaccharide-Induced Inflammatory Responses in BV2 Microglia by Inhibiting MAPK Signaling. Neurochemical Research. 41(7). 1570–1577. 15 indexed citations
13.
Wang, Jiangyan, Yuan Xie, Yan Feng, et al.. (2015). (−)-Epigallocatechingallate induces apoptosis in B lymphoma cells via caspase-dependent pathway and Bcl-2 family protein modulation. International Journal of Oncology. 46(4). 1507–1515. 33 indexed citations
14.
Xu, Ying, Jing Li, Shijie Ma, et al.. (2015). GSK3β mediates pancreatic cancer cell invasion in vitro via the CXCR4/MMP-2 Pathway. Cancer Cell International. 15(1). 70–70. 15 indexed citations
15.
Zhong, Jian‐Hong, Xiaoling Luo, Chao Ou, et al.. (2015). Clinicopathological characteristics and liver stem cell marker expression in hepatocellular carcinoma involving bile duct tumor thrombi. Tumor Biology. 37(5). 5879–5884. 13 indexed citations
16.
Shen, Xiaoyun, Yong Zhang, Yan Feng, et al.. (2014). Epigallocatechin-3-gallate inhibits cell growth, induces apoptosis and causes S phase arrest in hepatocellular carcinoma by suppressing the AKT pathway. International Journal of Oncology. 44(3). 791–796. 48 indexed citations
17.
Lai, Yunli, Zhenbo Zhang, Xiaoling Luo, et al.. (2012). The microRNA-27a: ZBTB10-specificity protein pathway is involved in follicle stimulating hormone-induced VEGF, Cox2 and survivin expression in ovarian epithelial cancer cells. International Journal of Oncology. 42(2). 776–784. 28 indexed citations
18.
Luo, Xiaoling, et al.. (2008). [Effects of hMIP-1beta gene modification on in vivo tumorigenicity and vaccine efficacy of tumor cells].. PubMed. 30(2). 97–102. 1 indexed citations
19.
Luo, Xiaoling, Yizhi Yu, Anmin Liang, et al.. (2004). Intratumoral expression of MIP-1beta induces antitumor responses in a pre-established tumor model through chemoattracting T cells and NK cells.. PubMed. 1(3). 199–204. 32 indexed citations
20.
Yu, Yizhi, Xiaoling Luo, Shuxun Liu, Yuan Xie, & Xuetao Cao. (2004). Intratumoral Expression of MIP-1b Induces Antitumor Responses in a Pre-Established Tumor Model through Chemoattracting T Cells and NK Cells.. Blood. 104(11). 5268–5268. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lin Zou Breakdown of academic impact, for papers by Xingsi Liang Breakdown of academic impact, for papers by Jiapeng Xu Breakdown of academic impact, for papers by Aimin Zang Breakdown of academic impact, for papers by Bing Wei Breakdown of academic impact, for papers by Yanping Li Breakdown of academic impact, for papers by Yanyi Xiao Breakdown of academic impact, for papers by Nageswara Rao Dunna Breakdown of academic impact, for papers by Yong Luo
Rankless by CCL
2026